Outcomes of Veno Arterial ECMO

NCT05155904 · tracked via the Priya Life Science France tracker

Sponsor

Centre Hospitalier Universitaire, Amiens

Phase

Observational

Started

2021-11-16

Last updated

2023-02-08

Condition(s) studied

MortalityExtra Corporeal Membrane Oxygenation

Study summary

veno arterial (VA) extra corporeal membrane oxygenation (ECMO) is a rescue therapy with various indications including refractory cardiac arrest and refractory cardiogenic shock. Amiens hospital university has an ECMO program and is a regional center to address patients requiring VA ECMO. In spite of the application of international guidelines, the mortality of patients with VA remains high with an admitted survival rate at hospital discharge at 40%.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * age : ≥ 18 * Patient with a VA ECMO Exclusion Criteria: * age\<18

Primary outcome measure(s)

In-hospital mortality — Up to hospital discharge, an average of 1 month
In-hospital mortality of patients with : veno arterial (VA) extra corporeal membrane oxygenation (ECMO)

Trial sites (1)

Facility	City	Region	Status
CHU Amiens Picardie	Amiens	France	Recruiting

More Centre Hospitalier Universitaire, Amiens trials in France

Intraoperative Sufentanil and Chronic Postsurgical Pain in Non-major Scheduled Abdominal Surgery Active, not recruiting

Epigenetic Biomarkers in the Saliva for the Diagnosis of Squamous Cells Carcinoma of the Oral Cavity Recruiting

Assessment of Venous Drainage in Idiopathic Intracranial Hypertension Active, not recruiting

Neonate Cerebral Activity in Immediate Post Partum Recruiting

Design of a Prototype Garment Adapted to Demented Elderly Subjects With Disturbing Behavioral Problems in the Management of Sphincter Disorders Active, not recruiting

Other trials for the same condition

National, Non Interventional Study of Invasive Pneumococcal Disease in Children and Newborns Recruiting

Modeling of Intracerebral Vascularization After Extracorporeal Membrane Oxygenation in Children Recruiting

Does High-dose Vitamin B3 Supplementation Prevent Major Adverse Kidney Events During Septic Shock? Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05155904 on ClinicalTrials.gov ↗ ← All trials in France